{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:4971",
      "entity_text" : "PpIX",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:Q02435",
      "entity_text" : "CP94",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Addition of CP94 to the ALA prodrug administration or alternatively utilising AP2-18, significantly increased PpIX fluorescence compared to ALA alone at all time points for all concentrations (Figs.",
  "reading_complete" : "2020-08-02T18:32:25Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T18:26:57Z",
  "trigger" : "increased",
  "evidence" : [ "CP94 to the ALA prodrug administration or alternatively utilising AP2-18, significantly increased PpIX" ],
  "pmc_id" : "6032951",
  "score" : 0
}